As the 119th Congress settles into its legislative rhythm, a critical conversation is unfolding that we, as patients and ...

For CrCl ≤15 mL/min, CKD stage V, no data available for any of the agents listed. ARISTOTLE indicates Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; bw, body ...

Though the United States of America faces its toughest budgetary and economic challenges since the Great Depression, it cannot afford to eliminate, or even reduce, its foreign assistance spending.

CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as ... important and has a considerable effect on patient distress, activities of daily living, and overall emotional ...

In patients with active cancer and venous thromboembolism, whether extended treatment with a reduced dose of an oral anticoagulant is effective in preventing recurrent thromboembolic events and ...